TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

3.50$ -2.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Foghorn Therapeutics Inc (FHTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 203 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FHTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
313 286 255 329 308 284 259 226 205 198 222 203
265 240 212 290 271 250 225 204 184 163 188 170
70 80 79 139 58 55 61 73 89 81 89 68
260 234 207 285 267 244 221 199 180 159 185 168
371 363 352 343 337 330 320 303 295 307 299 284
52 58 52 51 57 67 71 78 85 60 64 51
8.4 8.5 8.7 8.4 8.8 9.1 9.1 6.2 6.8 0.9 1.9 2.8
6.5 6.3 5.6 4.8 3.5 3.8 4.1 3.3 3.2 4.3 3.3 3.2
-57 -77 -97 -14 -28 -46 -62 -77 -90 -109 -76 -81
-447 -472 -497 -520 -539 -558 -577 -595 -611 -632 -652 -660
42 42 42 52 63 63 63 63 63 63 70 71

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?